Go Pro
NYSE:MD

Pediatrix Medical Group Q2 2026 Earnings Report

Pediatrix Medical Group logo
$26.48 -0.03 (-0.10%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$26.51 +0.03 (+0.10%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pediatrix Medical Group EPS Results

Actual EPS
N/A
Consensus EPS
$0.59
Beat/Miss
N/A
One Year Ago EPS
N/A

Pediatrix Medical Group Revenue Results

Actual Revenue
N/A
Expected Revenue
$478.49 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pediatrix Medical Group Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 4, 2026
Conference Call Time
9:00AM ET

Conference Call Resources

Pediatrix Medical Group Earnings Headlines

Pediatrix Medical Group : MD
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Pediatrix Medical Group Provides Second Quarter Update
See More Pediatrix Medical Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pediatrix Medical Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pediatrix Medical Group and other key companies, straight to your email.

About Pediatrix Medical Group

Pediatrix Medical Group (NYSE:MD) (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings. Pediatrix partners with hospitals, health systems and other healthcare providers across the United States to manage patient care programs, optimize clinical outcomes and support operational efficiencies. The company’s telehealth initiatives extend critical care expertise to remote and underserved locations while its research division advances evidence-based practices in neonatal and maternal-fetal medicine.

Under the leadership of President and CEO David R. Anderson, Pediatrix Medical Group emphasizes clinical quality, patient safety and physician engagement. The group supports more than 3,500 physicians and advanced practice clinicians and collaborates with over 1,300 facilities nationwide. Pediatrix continues to invest in clinical education, data analytics and population health management to meet the evolving needs of mothers, newborns and pediatric patients.

View Pediatrix Medical Group Profile